These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26027492)

  • 1. Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization.
    Li Y; Zhao X; Zu Y; Zhang Y
    Int J Pharm; 2015 Jul; 490(1-2):324-33. PubMed ID: 26027492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Carrier-Oriented Polygeline for Preparing Novel Polygeline-Bound Paclitaxel Nanoparticles.
    Xiong K; Wu J; Liu Y; Wu N; Ruan J
    J Pharm Sci; 2019 Jun; 108(6):2012-2021. PubMed ID: 30639741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study.
    Gora S; Mustafa G; Sahni JK; Ali J; Baboota S
    Drug Deliv; 2016; 23(3):940-50. PubMed ID: 24937379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
    Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The high water solubility of inclusion complex of taxifolin-γ-CD prepared and characterized by the emulsion solvent evaporation and the freeze drying combination method.
    Zu Y; Wu W; Zhao X; Li Y; Zhong C; Zhang Y
    Int J Pharm; 2014 Dec; 477(1-2):148-58. PubMed ID: 25455767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
    Nagaraj K; Narendar D; Kishan V
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel.
    Liang H; Yang Q; Deng L; Lu J; Chen J
    Drug Dev Ind Pharm; 2011 May; 37(5):597-605. PubMed ID: 21469948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.
    Patel K; Patil A; Mehta M; Gota V; Vavia P
    Int J Pharm; 2014 Sep; 472(1-2):214-23. PubMed ID: 24954663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
    Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R
    Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery.
    Wang Y; Li X; Wang L; Xu Y; Cheng X; Wei P
    Int J Nanomedicine; 2011; 6():1497-507. PubMed ID: 21796250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
    Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
    Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor.
    Chen L; Chen B; Deng L; Gao B; Zhang Y; Wu C; Yu N; Zhou Q; Yao J; Chen J
    Int J Pharm; 2017 Dec; 534(1-2):308-315. PubMed ID: 28986321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.
    Guo JJ; Yue PF; Lv JL; Han J; Fu SS; Jin SX; Jin SY; Yuan HL
    Int J Pharm; 2013 Jan; 441(1-2):227-33. PubMed ID: 23220096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.
    Ye X; Patil H; Feng X; Tiwari RV; Lu J; Gryczke A; Kolter K; Langley N; Majumdar S; Neupane D; Mishra SR; Repka MA
    AAPS PharmSciTech; 2016 Feb; 17(1):78-88. PubMed ID: 26283197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension.
    Cao Y; Wei Z; Li M; Wang H; Yin L; Chen D; Wang Y; Chen Y; Yuan Q; Pu X; Zong L; Duan S
    Curr Cancer Drug Targets; 2019; 19(4):338-347. PubMed ID: 29956630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.
    Ambrus R; Kocbek P; Kristl J; Sibanc R; Rajkó R; Szabó-Révész P
    Int J Pharm; 2009 Nov; 381(2):153-9. PubMed ID: 19616609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability.
    Shen G; Cheng L; Wang LQ; Zhang LH; Shen BD; Liao WB; Li JJ; Zheng J; Xu R; Yuan HL
    Chin J Nat Med; 2016 Oct; 14(10):757-768. PubMed ID: 28236405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.